The Therapeutic Effects and Pathophysiology of Botulinum Toxin a on Voiding Dysfunction Due to Urethral Sphincter Dysfunction

Toxins - Switzerland
doi 10.3390/toxins11120728
Full Text
Abstract

Available in full text

Date
Authors
Publisher

MDPI AG

Related search

Type a Botulinum Toxin in Myofascial Facial Pain and Dysfunction

2003English

Urethral Dysfunction Due to Alloxan-Induced Diabetes. Urodynamic and Morphological Evaluation

Acta Cirurgica Brasileira
Surgery
2014English

A New Approach to Identify Sphincter of Oddi Dysfunction

Journal of Advances in Radiology and Medical Imaging
2016English

Two Cases With Down Syndrome Manifesting as Acute Urinary Retention Due to Voiding Dysfunction

Nihon Shoni Jinzobyo Gakkai Zasshi
2015English

The Pathophysiology of Erectile Dysfunction Related to Endothelial Dysfunction and Mediators of Vascular Function

Vascular Medicine
MedicineCardiovascular MedicineCardiology
2002English

Cardiac Effects of Muscarinic Receptor Antagonists Used for Voiding Dysfunction

British Journal of Clinical Pharmacology
Pharmacology
2011English

Translational and Clinical Perspectives on Sphincter of Oddi Dysfunction

Clinical and Experimental Gastroenterology
Gastroenterology
2016English

The Forefront for Novel Therapeutic Agents Based on the Pathophysiology of Lower Urinary Tract Dysfunction: Α-Blockers in the Treatment of Male Voiding Dysfunction — How Do They Work and Why Do They Differ in Tolerability?

Journal of Pharmacological Sciences
Molecular MedicinePharmacology
2010English

Achalasia in Pregnancy: Botulinum Toxin a Injection of Lower Esophageal Sphincter

Case Reports in Surgery
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy